HR Execs on the Move

First Primary Care

www.firstprimarycare.com

 
First Primary Care is a direct primary care practice that provides personalized, accessible, cost-effective, modern care to each member of your family. They offer unrestricted, no-wait access to primary care physicians through in-person visits, text, o...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Rocky Knoll Health Care Facilitly

Rocky Knoll Health Care Facilitly is a Plymouth, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Obstetrical and Gynecological Associates

Obstetrical and Gynecological Associates is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Obstetrical and Gynecological Associates is based in Houston, TX. You can find more information on Obstetrical and Gynecological Associates at www.obgynassociates.com

Hale Ho Aloha Icf

Hale Ho Aloha Icf is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedRisk

MedRisk is the leading provider of managed physical medicine for the workers` compensation industry and related market sectors. Unified through a uniquely integrated, US-based support model, we pride ourselves in combining clinical expertise with highly personal service and responsiveness. This focus allows us to offer distinct value to each stakeholder in the workers` comp process – carriers and TPAs, employers, adjusters and case managers, physicians, network providers and the patients themselves. In short, we`re here for you; at MedRisk, you`re never just a number – you`re an individual who deserves a solution tailored to your exact needs. We`re here to help you reach your goals and improve your outcomes – whatever they may be.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.